FDA Brief

Company record

Fresenius Kabi Compounding, LLC

0 FDA warning letters since 2023 and 5 recalls in the last 12 months.

Get an email the day FDA posts anything new about Fresenius Kabi Compounding, LLC.

Recalls

ReportedClassFirmProduct and reason
Feb 18 Class II Fresenius Kabi Compounding, LLC
Drug
thiamine HCl, 500 mg, 500 mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-079-56.
Lack of Assurance of Sterility
FDA notice D-0335-2026
Feb 18 Class II Fresenius Kabi Compounding, LLC
Drug
ketamine HCl, 1,000 mg, 1,000 mg per 100 mL (10 mg per mL) in Sodium Chloride Injection, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-050-56
Lack of Assurance of Sterility
FDA notice D-0334-2026
Feb 18 Class II Fresenius Kabi Compounding, LLC
Drug
vancomycin HCl, 1.5 grams, 1.5 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-016-59
Lack of Assurance of Sterility
FDA notice D-0336-2026
Feb 18 Class II Fresenius Kabi Compounding, LLC
Drug
vancomycin HCl, 2 grams, 2 grams added to 500 mL, 0.9% Sodium Chloride Injection, USP, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-019-59.
Lack of Assurance of Sterility
FDA notice D-0337-2026
Feb 18 Class II Fresenius Kabi Compounding, LLC
Drug
acyclovir sodium, 200 mg, 200mg added to 100 mL, 0.9% Sodium Chloride Injection, USP, For Intravenous Use, Single-Use Bag, Fagron Sterile Services, 20 Dan Road, Canton, MA 02021, NDC 71506-035-56
Lack of Assurance of Sterility
FDA notice D-0333-2026